Effect of hesperidin on expression of inducible nitric oxide synthase in cultured rabbit retinal pigment epithelial cells

Advances in Experimental Medicine and Biology

Volumn 664, Issue , 2010, Pages 193-201

  Xiaoting, Luo ^b   Xiangyun, Zeng ^b   Shumei, Li ^a   Minghua, Dong ^b   Liang, Xiong ^b  

^a GANNAN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HESPERIDIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITROGEN OXIDE;

ANIMAL CELL; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; IN VITRO STUDY; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

ANALYSIS OF VARIANCE; ANIMALS; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; GLUCOSE; HESPERIDIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PIGMENT EPITHELIUM OF EYE; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 79959613100     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1399-9_22     Document Type: Conference Paper

References (13)

1. Civan MM, Marano CW,Matschinsky FW et al (1994) Prolonged incubation with elevated glucose inhibits the regulatory response to shrinkage of cultured human retinal pigment epithelial cells. J Membr Biol 139(1):1-13 (Pubitemid 24122571)
2. Hong J, Yuan Z, Shuai J et al (2007) High glucose induce production of iNOS by human retinal pigment epithelium cells through activation of the p38 signal pathway. Acta Universitatis Medicinalis Nanjing (Natural Science) 27(9):970-973
3. Izumi N, Nagaoka T, Mori F et al (2006) Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol 50(5):465-468 (Pubitemid 44496515)
4. Kanaze FI, Gabrieli C, Kokkalou E et al (2003) Simultaneous reversed-phase high-performance liquid chromatographic method for the determination of diosmin, hesperidin and naringin in different citrus fruit juices and pharmaceutical formulations. J Pharm Biomed Anal 33(2): 243-249 (Pubitemid 37101441)
5. Leal EC, Manivannan A, Hosoya K et al (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48(11):5257-5265 (Pubitemid 351260939)
6. Luo X, Li S (2008) Progress in Biologic Activity Effects of Hesperidin. J Gannan Med Univ 28(2):301-304
7. Madsen-Bouterse SA, Kowluru RA (2008) Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 9(4): 315-327
8. Rao YK, Fang SH, Tzeng YM (2008) Antiinflammatory activities of flavonoids and a triterpene caffeate isolated from Bauhinia variegata. Phytother Res 22(7):957-962
9. Roufail E, Soulis T, Boel E et al (1998) Depletion of nitric oxide synthase-containing neurons in the diabetic retina: Reversal by aminoguanidine. Diabetologia 41(12):1419-1425 (Pubitemid 28551612)
10. Sakata K, Hirose Y, Qiao Z et al (2003) Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 199(2):139-145 (Pubitemid 37297707)
11. Shashi W, Tapas CN (1999) Nitric oxide synthase immunoreactivity in the developing and adult human retina. J Biosci 24(4):483-490
12. Toda N, Nakanishi-Toda M (2007) Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 26(3):205-238 (Pubitemid 46498800)
13. Tommasini S, Calabrò ML, Stancanelli R et al (2005) The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta- cyclodextrin. J Pharm Biomed Anal 39 (3-4):572-580 (Pubitemid 41196065)